These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21177677)

  • 21. Rifampicin resistance in tuberculosis outbreak, London, England.
    Jenkins C
    Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
    De Kantor IN
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
    Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.
    Strydom K; Ismail F; Matabane MM; Onwuegbuna O; Omar SV; Ismail N
    J Clin Microbiol; 2015 Sep; 53(9):3032-4. PubMed ID: 26135869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
    Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM
    Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
    Piana A; Orrù M; Masia MD; Sotgiu G; Muresu E; Maida A
    New Microbiol; 2003 Oct; 26(4):375-81. PubMed ID: 14596348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
    Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
    J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
    Miotto P; Piana F; Migliori GB; Cirillo DM
    New Microbiol; 2008 Jan; 31(1):147-50. PubMed ID: 18437855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM
    J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
    Afanas'ev MV; Ikriannikova LN; Il'ina EN; Smirnova TG; Larionova EE; Kuz'min AV; Chernousova LN; Kamaev EIu; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    Probl Tuberk Bolezn Legk; 2007; (7):37-42. PubMed ID: 17722291
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.
    Yang Z; Durmaz R; Yang D; Gunal S; Zhang L; Foxman B; Sanic A; Marrs CF
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):201-8. PubMed ID: 16243477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
    Hauck Y; Fabre M; Vergnaud G; Soler C; Pourcel C
    J Antimicrob Chemother; 2009 Aug; 64(2):259-62. PubMed ID: 19520715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.